trending Market Intelligence /marketintelligence/en/news-insights/trending/ud7znkdm77ionxu5y5ia6q2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

LexaGene Holdings names director

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


LexaGene Holdings names director

LexaGene Holdings Inc. appointed Joseph Caruso as a board member.

Caruso currently serves as a board member of Endocellutions Inc., a privately held medical device company. He was a member of Launchpad Venture Group, a Boston-based investment group providing funding and advice to early stage companies, from 2016 to 2018.

Lexagene Holdings engages in the research, development and commercialization of pathogen detection devices to the bio-chemical industry in the U.S.